Article Text
Editorial
Nicotine replacement therapy for smoking cessation in the “real world”
Statistics from Altmetric.com
Footnotes
Dr Shiffman serves as a consultant to GlaxoSmithKline Consumer Healthcare (GSKCH) on an exclusive basis regarding matters relating to smoking cessation, and also has a financial interest in a venture to develop a new nicotine replacement medication.